Acadian Asset Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $265K | Sell |
59,481
-5,189
| -8% | -$20.7K | ﹤0.01% | 1512 |
|
|
2025
Q4 | $245K | Buy |
+64,670
| New | +$252K | ﹤0.01% | 1478 |
|
|
2025
Q2 | – | Sell |
-53,239
| Closed | -$113K | – | 1763 |
|
|
2025
Q1 | $113K | Buy |
+53,239
| New | +$168K | ﹤0.01% | 1337 |
|
|
2024
Q1 | – | Sell |
-22,692
| Closed | -$103K | – | 1694 |
|
|
2023
Q4 | $103K | Sell |
22,692
-13,255
| -37% | -$44.7K | ﹤0.01% | 1351 |
|
|
2023
Q3 | $141K | Sell |
35,947
-91,280
| -72% | -$345K | ﹤0.01% | 1252 |
|
|
2023
Q2 | $397K | Buy |
127,227
+53,804
| +73% | +$220K | ﹤0.01% | 1109 |
|
|
2023
Q1 | $331K | Buy |
+73,423
| New | +$384K | ﹤0.01% | 1145 |
|
|
2021
Q3 | – | Sell |
-457
| Closed | -$4K | – | 1884 |
|
|
2021
Q2 | $4K | Buy |
+457
| New | +$5.16K | ﹤0.01% | 1968 |
|
|
2020
Q3 | – | Sell |
-20,106
| Closed | -$259K | – | 2280 |
|
|
2020
Q2 | $259K | Buy |
+20,106
| New | +$234K | ﹤0.01% | 1408 |
|
|
2019
Q4 | – | Sell |
-14,830
| Closed | -$131K | – | 1996 |
|
|
2019
Q3 | $131K | Buy |
+14,830
| New | +$163K | ﹤0.01% | 1420 |
|
|
2019
Q2 | – | Sell |
-11,806
| Closed | -$389K | – | 1948 |
|
|
2019
Q1 | $389K | Buy |
+11,806
| New | +$605K | ﹤0.01% | 1175 |
|
|
2018
Q4 | – | Sell |
-657
| Closed | -$92K | – | 1778 |
|
|
2018
Q3 | $92K | Sell |
657
-3,438
| -84% | -$417K | ﹤0.01% | 1221 |
|
|
2018
Q2 | $502K | Sell |
4,095
-1,881
| -31% | -$160K | ﹤0.01% | 893 |
|
|
2018
Q1 | $534K | Sell |
5,976
-2,692
| -31% | -$228K | ﹤0.01% | 842 |
|
|
2017
Q4 | $481K | Buy |
8,668
+1,339
| +18% | +$60.3K | ﹤0.01% | 808 |
|
|
2017
Q3 | $310K | Buy |
7,329
+112
| +2% | +$4.66K | ﹤0.01% | 850 |
|
|
2017
Q2 | $304K | Buy |
+7,217
| New | +$369K | ﹤0.01% | 900 |
|
Other funds holding LRMR
DM
BOCH
ACM
DCM
VCM
DCM
DTC